INBRAIN Neuroelectronics has secured funding that will allow the company to rapidly advance its development of graphene-based brain implants that could aid in the treatment of neurological disorders like Parkinson’s and epilepsy.
INBRAIN was formed in 2019 to find ways of creating brain implants using graphene technology. The idea is for the implants to translate signals sent by the brain and automatically react with the appropriate therapeutic response.
“Within the framework of the Graphene Flagship, which is a European macroproject”, explains ICREA Professor Jose Garrido, “we were able to develop this novel graphene-based technology that will allow measuring and stimulating neuronal activity in the brain with a resolution much higher than that of current commercial technologies”.
The company hopes its breakthrough will lead to a better understanding of how the human brain works and improve neurologists’ ability to diagnose and treat disorders of the brain.
The company, which spun out of the Catalan Institute of Nanoscience and Nanotechnology, Barcelona Institute of Science and Technology, and Catalan Institution for Research and Advanced Studies, got the funding from Sabadell Asabys and Alta Life Sciences, as well as ICF and Finaves, according to Graphene-Info.com.
The technology has been successfully tested on small animals. It’s currently trying it on larger animals with human trials expected to start before long.